Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer

This study has been completed.
Information provided by (Responsible Party):
Geron Corporation Identifier:
First received: December 2, 2010
Last updated: December 22, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 13, 2015